Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W15D | ISIN: US00182C1036 | Ticker-Symbol: BSFA
Tradegate
31.03.25
15:50 Uhr
61,00 Euro
-2,00
-3,17 %
1-Jahres-Chart
ANI PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ANI PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
61,5062,5022:03
61,5062,0022:00

Aktuelle News zur ANI PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.03.ANI Pharmaceuticals Launches Nitazoxanide Tablets 500 Mg200WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia.Nikhil...
► Artikel lesen
19.03.ANI Pharmaceuticals launches generic Nitazoxanide Tablets2
19.03.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets107PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI's Nitazoxanide Tablets...
► Artikel lesen
19.03.ANI Pharmaceuticals Eliminates Royalty Obligation On ILUVIEN And YUTIQ321WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) Tuesday has completed the buyout of its 3.125 percent perpetual royalty obligation to SWK Funding LLC on global net revenues of ILUVIEN...
► Artikel lesen
18.03.ANI Pharma buys royalties linked to Iluvien and Yutiq2
18.03.ANI PHARMACEUTICALS INC - 8-K, Current Report1
18.03.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN and YUTIQ87BAUDETTE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the buyout of its 3.125% perpetual royalty obligation...
► Artikel lesen
ANI PHARMACEUTICALS Aktie jetzt für 0€ handeln
14.03.Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts3
14.03.ANI Pharma Says FDA Approves Expanded ILUVIEN Label To Treat Chronic NIU-PS293WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN (fluocinolone acetonide intravitreal...
► Artikel lesen
14.03.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN Label247ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing...
► Artikel lesen
14.03.Jefferies initiates ANI Pharmaceuticals stock with Buy, $80 target4
12.03.ANI Pharma wins Overweight rating at J.P. Morgan on growth prospects2
12.03.JPMorgan sets ANI Pharmaceuticals stock at $85 target2
11.03.ANI PHARMACEUTICALS INC - 8-K, Current Report1
07.03.ANI Pharmaceuticals: Leitender Vizepräsident verkauft Aktien im Wert von 323.049 US-Dollar1
04.03.ANI Pharmaceuticals (NASDAQ:ANIP) Issues FY 2025 Earnings Guidance2
04.03.ANI Pharmaceuticals Receives FDA Approval For Purified Cortrophin Gel Prefilled Syringe307WASHINGTON (dpa-AFX) - ANI Pharmaceuticals Inc. (ANIP) announced that the U.S. Food and Drug Administration approved Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin...
► Artikel lesen
03.03.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel Prefilled Syringe259PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin®...
► Artikel lesen
03.03.ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript1
03.03.Truist maintains hold on ANI Pharmaceuticals, keeps $62 target3
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1